JAK3/STAT signaling drives the expression of oncogenic miRs such as miR-155, miR-21, miR-93, and miR-214 [19,20] as well as repression of putative tumour suppressors (SATB1, PDCD4, JARID2) in malignant T cells [18,21,22]. Here, JAK3 is linked to neoplasm.